We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Software for Rapid Cell Count and Analysis

By HospiMedica staff writers
Posted on 05 Apr 2004
New software is based on an innovative cluster analysis algorithm designed to provide more precise, accurate, and automated absolute cell counting and viability measurements.

Accuracy, reproducibility, and standardization are essential to successful outcomes in laboratories that perform cell count and viability assessments. More...
Traditional methods for counting cells and assessing cell viability are time consuming. Moreover, they may produce variable results because of reliance on subjective visual discrimination of dye-stained cells using a hemacytometer and microscope.

The ViaCount Assay of Guava Technologies, Inc. (Hayward, CA, USA) is a simple, accurate, and reproducible test for absolute cell counting and viability measurements that overcomes many of the limitations of traditional methods. The assay reduces statistical variation by sampling large numbers of single cells, and miniaturizes operator variability by using fluorescence intensity measurements to categorize cells as live, dead, or apoptotic. Now, the system is enhanced with the Guava EasyFit software feature that automates and standardizes cell counting and viability assessments.

The software provides a computer-assisted clustering algorithm to group cellular distributions based on their positions in a 3D matrix. Cells are classified and counted based on three individual measurements of each cell, including the fluorescence intensity values for the live and dead cell based on the uptake of dyes in Guava's ViaCount solution.

"EasyFit provides users of our product with a means to operate the system without the need for manual adjustment of gating parameters,” said Keith Olson, director of product commercialization at Guava Technologies. The company is a leading provider of integrated microcytometry and cell counting systems for the life science, biotechnology, and pharmaceutical industries, as well as for use in clinical testing and blood processing and other areas where single cell counting is important.




Related Links:
Guava Technologies

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Radiology System
Riviera SPV AT
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.